The selection of appropriate biological samples is crucial for the molecular diagnosis of viral diseases, as sample type significantly influences the accuracy, sensitivity, and reliability of diagnostic outcomes. This chapter provides an overview of various clinical specimens, including blood, saliva, urine, nasopharyngeal swabs, and cerebrospinal fluid, highlighting their advantages and limitations in molecular testing. Blood is widely used due to its high viral load in systemic infections, but it requires invasive collection. Saliva and urine offer non-invasive alternatives and are suitable for detecting certain viruses, though they may have lower viral concentrations. Nasopharyngeal and oropharyngeal swabs are standard for respiratory viruses like SARS-CoV-2 and influenza but may present challenges in sample collection and handling. Cerebrospinal fluid is critical for diagnosing neurotropic viral infections but necessitates specialized procedures. The chapter also discusses the role of specimen stability, transport conditions, and pre-analytical variables in optimizing molecular diagnostic efficiency. Understanding the pros and cons of different sample types allows for informed decisions in clinical and research settings, ensuring effective viral detection and disease management. The chapter concludes by emphasizing the need for standardized guidelines and emerging techniques to enhance sample collection and molecular diagnostic accuracy.